Cargando…
Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer
Dystroglycan is frequently lost in adenocarcinoma, but the mechanisms and consequences are poorly understood. We report an analysis of β-dystroglycan in prostate cancer in human tissue samples and in LNCaP cells in vitro. There is progressive loss of β-dystroglycan immunoreactivity from basal and la...
Autores principales: | Mathew, G., Mitchell, A., Down, J. M., Jacobs, L. A., Hamdy, F. C., Eaton, C., Rosario, D. J., Cross, S. S., Winder, S. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786294/ https://www.ncbi.nlm.nih.gov/pubmed/24077328 http://dx.doi.org/10.1038/srep02792 |
Ejemplares similares
-
γ‐Secretase Dependent Nuclear Targeting of Dystroglycan
por: Leocadio, Daniel, et al.
Publicado: (2016) -
Dystroglycan versatility in cell adhesion: a tale of multiple motifs
por: Moore, Chris J, et al.
Publicado: (2010) -
Retrograde trafficking of β-dystroglycan from the plasma membrane to the nucleus
por: Gracida-Jiménez, Viridiana, et al.
Publicado: (2017) -
Dystroglycan and dystroglycanopathies: Report of the 187th ENMC Workshop 11–13 November 2011, Naarden, The Netherlands
por: Brown, Susan C., et al.
Publicado: (2012) -
Dystroglycan, Tks5 and Src Mediated Assembly of Podosomes in Myoblasts
por: Thompson, Oliver, et al.
Publicado: (2008)